MedTrace Logo

Comparison of Refined and Crude Indigo Naturalis Ointment in Treating Psoriasis

NCT01022502 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2012-10-16

Study results available
· View outcomes & findings →

Summary

To compare the efficacy and safety of refined indigo naturalis ointment with that of crude ointment in treating psoriasis.

Conditions

  • Psoriasis Vulgaris

Interventions

DRUG

refined indigo naturalis ointment

The patients applied either refined oil extract or crude indigo naturalis ointmnet topically to each of two bilaterally symmetrical psoriatic plaque lesions for 8 weeks.

DRUG

crude indigo naturalis ointment

The patients applied either refined oil extract or crude indigo naturalis ointmnet topically to each of two bilaterally symmetrical psoriatic plaque lesions for 8 weeks.

Sponsors & Collaborators

  • Yin-ku Lin

    lead OTHER

Principal Investigators

  • Yin-Ku Lin, MD. PhD. · Chang Gung Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01022502 on ClinicalTrials.gov